UConn Today – Nami Therapeutics Corporation, which gets its name from the Mandarin word for “nano,” is committed to using nanotechnologies to make big advances in cancer therapy. An early-stage startup led by researchers at the University of Connecticut and the University of North Carolina at Chapel Hill, Nami Therapeutics is developing specifically designed nanoparticles for targeted drug delivery.
Nami Therapeutics Startup Pursues Promising Drug Therapy
November 6, 2019



